Where I see patients (1)
My reviews
Selected research
-
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.
Blood advances
-
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial.
Clinical lymphoma, myeloma & leukemia
-
It's All in the Timing.
The New England journal of medicine
Clinical trials
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
The feasibility of completing molecular, genetic, immunophenotypic, and biochemical testing for assignment of therapy will be assessed based on the proportion of patients for whom testing is completed within 7 days of the registra...
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9